Sundhedsvidenskabelig Forskning ved Aarhus - Institutleder til ...

HÆMATOLOGISK AFDELING R, ÅRHUS UNIVERSITETSHOSPITAL, ÅRHUS SYGEHUS
phase II trial’, Hematology Reviews, vol. 1, nr. 2, s.
62-64.
Jørgensen, J, Sørensen, F, Bendix, K, Nielsen, J, Funder,
A, Karkkainen, M, Tainola, T, Sørensen, AB,
Pedersen, FS & D’Amore, F 2009, ‘Expression level,
tissue distribution pattern, and prognostic impact
of vascular endothelial growth factors VEGF and
VEGF-C and their receptors Flt-1, KDR, and Flt-4
in different subtypes of non-Hodgkin lymphomas’,
Leukemia and Lymphoma, s. 1-14.
Karrman, K, Kjeldsen, E, Lassen, C, Isaksson, M,
Davidsson, J, Andersson, A, Hasle, H, Fioretos, T &
Johansson, B 2009, ‘The t(X;7)(q22;q34) in paediatric
T-cell acute lymphoblastic leukaemia results
in overexpression of the insulin receptor substrate
4 gene through illegitimate recombination with
the T-cell receptor beta locus’, British Journal of
Haematology, vol. 144, nr. 4, s. 546-51.
Ommen, HB, Ostergaard, M, Yan, M, Brændstrup, K,
Zhang, D & Hokland, P 2009, ‘Persistent altered
fusion transcript splicing identifies RUNX1-
RUNX1T1+ AML patients likely to relapse’, European
Journal of Haematology. E-pub ahead of print..
Petersen, L, Roug, AS, Skovbo, A, Thysen, AH, Eskelund,
CW & Hokland, M 2009, ‘The CD94/NKG2Cexpressing
NK cell subset is augmented in chronic
lymphocytic leukemia patients with positive
human cytomegalovirus serostatus’, Viral Immunology,
vol. 22, nr. 5, s. 333-7.
Søndergaard, CS, Bonde, J, Dagnæs-Hansen, F, Nielsen,
JM, Zachar, V, Holm, MS, Hokland, P & Pedersen, L
2009, ‘ Minimal engraftment of human CD34+ cells
mobilized from healthy donors in the infarcted heart
of athymic nude rats’, Stem Cells and Development,
vol. 18, nr. 6, s. 845-56.
Søndergaard, CS, Haldrup, C, Beer, C, Andersen, B,
Kohn, DB & Pedersen, L 2009, ‘Preloading Potential
of Retroviral Vectors is Packaging Cell Clone
Dependent and Centrifugation onto CH-296 Ensures
Highest Transduction Efficiency’, Human Gene
Therapy, vol. 20, nr. 4, s. 337-49.
Vangsted, AJ, Klausen, TW, Ruminski, W, Gimsing, P,
Andersen, NF, Gang, AO, Abildgaard, N, Knudsen,
LM, Nielsen, JL, Gregersen, H & Vogel, U 2009, ‘The
polymorphism IL-1beta T-31C is associated with
a longer overall survival in patients with multiple
myeloma undergoing Auto-SCT’, Bone Marrow
Transplantation, vol. 43, nr. 7, s. 539-45.
Vangsted, AJ, Klausen, TW, Gimsing, P, Andersen, NF,
Abildgaard, N, Gregersen, H & Vogel, U 2009, ‘A
polymorphism in NFKB1 is associated with improved
effect of interferon-{ alpha} maintenance
treatment of patients with multiple myeloma
after high-dose treatment with stem cell support’,
Haematologica, vol. 94, nr. 9, s. 1274-81.
Zangenberg, M, Grubach, L, Aggerholm, A, Silkjaer,
T, Juhl-Christensen, C, Nyvold, CG, Kjeldsen, E,
Ommen, HB & Hokland, P 2009, ‘The combined
expression of HOXA4 and MEIS1 is an independent
prognostic factor in patients with AML’, European
Journal of Haematology, vol. 83, nr. 5, s. 439-48.
d’Amore, FA, Jantunen, E & Relander, T 2009, ‘Hemopoietic
Stem Cell Transplantation in T-cell
Malignancies:Who, When and How?’, Current Hematologic
Malignancy Reports, vol. 4, s. 236-244.
Artikel
Baccarani, M, Rosti, G, Castagnetti, F, Haznedaroglu,
I, Porkka, K, Abruzzese, E, Alimena, G, Ehrencrona,
H, Hjorth-Hansen, H, Kairisto, V, Levato, L,
Martinelli, G, Nagler, A, Lanng Nielsen, J, Ozbek, U,
Palandri, F, Palmieri, F, Pane, F, Rege-Cambrin, G,
Russo, D, Specchia, G, Testoni, N, Weiss-Bjerrum,
O, Saglio, G & Simonsson, B 2009, ‘Comparison of
imatinib 400 mg and 800 mg daily in the front-line
treatment of high-risk, Philadelphia-positive chronic
myeloid leukemia: a European LeukemiaNet
Study’, Blood, vol. 113, nr. 19, s. 4497-504.
Hokland, P, Nyvold, CG, Stentoft, J, Ommen, HB,
Hyldahl, L, Braendstrup, K, Andersen, BL, Siig, L
& Ostergaard, M 2009, ‘Minimal restsygdom ved
maligne blodsygdomme I. Baggrund og praeklinisk
validering’, Ugeskrift for læger, vol. 171, nr. 4, s.
229-31.
Hokland, P, Ommen, HB, Nyvold, CG, Stentoft, J, Braendstrup,
K, Andersen, BL, Siig, L & Ostergaard, M
2009, ‘Minimal restsygdom ved maligne blodsygdomme
II. Translation og terapeutiske konsekvenser’,
Ugeskrift for læger, vol. 171, nr. 4, s. 232-5.
Mylin, AK, Andersen, NF, Johansen, JS, Abildgaard, N,
Heickendorff, L, Standal, T, Gimsing, P & Knudsen,
LM 2009, ‘Serum YKL-40 and bone marrow angiogenesis
in multiple myeloma’, International Journal
of Cancer, vol. 124, nr. 6, s. 1492-4.
d’Amore, FA, Jantunen, E & Relander, T 2009, ‘Hemopoetic
Stem Cell Transplantation in T-Cell Malignancies:
Who, When and How?’, Current Hematologic
Malignancy Reports.
Sundhedsvidenskabelig Forskning ved Aarhus Universitet og Århus Universitetshospital 2009 129